Understanding SARS-CoV-2 and the drugs that might lessen its power

Indonesia Berita Berita

Understanding SARS-CoV-2 and the drugs that might lessen its power
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 TheEconomist
  • ⏱ Reading Time:
  • 77 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 34%
  • Publisher: 92%

Just a few months ago the virus took its first steps into a human host. As of this week there were over 120,000 diagnosed cases around the world

; in cell-culture studies it both reduces the virus’s ability to get into cells and its ability to reproduce once inside them, possibly by altering the acidity of the Golgi apparatus. Camostat mesylate, which is used in cancer treatment, blocks the action of proteases similar toNot all drugs need to target the virus. Some could work by helping the immune system.

Conversely, parts of the immune system are too active in covid-19. The virus kills not by destroying cells until none are left, but by overstimulating the immune system’s inflammatory response. Part of that response is mediated by a molecule called interleukin-6—one of a number of immune-system modulators that biotechnology has targeted because of their roles in autoimmune disease.

Actemra is an antibody that targets the interleukin-6 receptors on cell surfaces, gumming them up so that the interleukin-6 can no longer get to them. It was developed for use in rheumatoid arthritis. China has just approved it for use against covid-19. There are anecdotal reports of it being associated with clinical improvements in Italy.

While many trials are under way in China, the decline in the case rate there means that setting up new trials is now difficult. In Italy, where the epidemic is raging, organising trials is a luxury the health system cannot afford. So scientists are dashing to set up protocols for further clinical trials in countries expecting a rush of new cases. Dr Farrar said on March 9th that Britain must have its trials programme agreed within the week.

In the lab, SARS-CoV-2 will continue being dissected and mulled over. Details of its tricksiness will be puzzled out, and the best bits of proteins to turn into vaccines argued over. But that is all for tomorrow. For today doctors can only hope that a combination of new understanding and not-so-new drugs will do some good.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

TheEconomist /  🏆 6. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Pence: Americans won’t get ‘surprise’ medical bills for coronavirus testsPence: Americans won’t get ‘surprise’ medical bills for coronavirus testsPeople who get tested for the COVID-19, the disease caused by the new virus SARS-CoV-2, don’t have to worry about getting a surprise medical bill, Vice...
Baca lebih lajut »

The COVID-19 Coronavirus Is Now A Pandemic: What Does That Mean?The COVID-19 Coronavirus Is Now A Pandemic: What Does That Mean?Today the World Health Organization (WHO) officially called the SARS-CoV2 outbreak a pandemic.
Baca lebih lajut »

Coronavirus: Travelers And Airlines Scramble After Trump Announces European Travel BanCoronavirus: Travelers And Airlines Scramble After Trump Announces European Travel BanThe travel industry could lose seven times more money than during the 2002-2003 SARS outbreak.
Baca lebih lajut »

Missouri Sues Televangelist Jim Bakker for Selling Fake Cure to 'Kill or Deactivate' CoronavirusMissouri Sues Televangelist Jim Bakker for Selling Fake Cure to 'Kill or Deactivate' the Coronavirus
Baca lebih lajut »

12 Political Podcasts to Help You Figure Out What the Hell Is Happening12 Political Podcasts to Help You Figure Out What the Hell Is HappeningThe 12 Best Political Podcasts to Listen to Right Now
Baca lebih lajut »



Render Time: 2025-03-10 23:39:31